Related Experiment Video

Updated: Jul 20, 2025

In vitro Measurements of Tracheal Constriction Using Mice

In vitro Measurements of Tracheal Constriction Using Mice

Published on: June 25, 2012

Prorelaxant E-type Prostanoid Receptors Functionally Partition to Different Procontractile Receptors in Airway Smooth

Ajay P Nayak¹, Elham Javed¹, Dominic R Villalba¹

¹Center for Translational Medicine, Jane and Leonard Korman Lung Institute, Division of Pulmonary, Allergy & Critical Care Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania.

American Journal of Respiratory Cell and Molecular Biology

|July 31, 2023

Summary

Prostaglandin E2 receptors EP2 and EP4 differentially regulate airway smooth muscle contraction. EP4 activation more effectively relaxes methacholine-induced contractions than EP2, impacting airway smooth muscle function.

Area of Science:

Pharmacology
Respiratory Medicine
Cellular Biology

Background:

Prostaglandin E2 (PGE2) exerts diverse physiological effects via four E-type prostanoid (EP) receptor subtypes (EP1-EP4).
Gs-coupled EP2 and EP4 receptors are present on airway smooth muscle (ASM), but their role in regulating ASM contractile state is debated.
Understanding EP receptor function is crucial for developing targeted therapies for airway diseases.

Purpose of the Study:

To investigate the distinct roles of EP2 and EP4 receptors in regulating human ASM contraction and signaling.
To compare the efficacy of EP2- and EP4-specific agonists in relaxing ASM under various contractile stimuli.
To elucidate the signaling pathways involved in EP receptor-mediated regulation of ASM contractility.

Main Methods:

Utilized subtype-specific agonists ONO-259 (EP2) and ONO-329 (EP4).
Employed cell- and tissue-based models: magnetic twisting cytometry (MTC) for ASM cells and precision-cut lung slices (PCLSs) for tissue-level responses.
Assessed ASM contraction and signaling (VASP, HSP20, pMLC20 phosphorylation, F/G-actin ratio) under histamine or methacholine (MCh) stimulation.

Main Results:

ONO-329 (EP4 agonist) demonstrated superior relaxation of MCh-contracted PCLSs compared to ONO-259 (EP2 agonist).
Both agonists showed similar efficacy in relaxing histamine-contracted PCLSs, indicating agonist- and stimulus-dependent effects.
EP4 activation (ONO-329) effectively reversed MCh- and histamine-induced changes in pMLC20 and F/G-actin ratio, unlike EP2 activation (ONO-259) with MCh.

Conclusions:

EP4 receptors play a more significant role in relaxing methacholine-induced ASM contraction than EP2 receptors.
Differential effects of EP2 and EP4 agonists are linked to the regulation of myosin light chain phosphorylation and actin cytoskeleton dynamics, not global PKA substrate phosphorylation.
Findings suggest compartmentalized signaling involving muscarinic, histamine, and EP receptor subtypes in regulating ASM contractility.

Keywords:

ASM G protein-coupled receptor asthma compartmentalization prostaglandin

More Related Videos

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses

Isolation of Intrapulmonary Artery and Smooth Muscle Cells to Investigate Vascular Responses

Published on: June 8, 2022

Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle

Utilizing the Precision-Cut Lung Slice to Study the Contractile Regulation of Airway and Intrapulmonary Arterial Smooth Muscle

Published on: May 5, 2022

Related Concept Videos

Adrenergic Receptors: ɑ Subtype

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...

Adrenergic Receptors: β Subtype

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...

Antihypertensive Drugs: Types of β-Blockers

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and...

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic Receptors (Adrenoceptors): Classification

Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

Cholinergic Receptors: Muscarinic

Cholinergic Receptors: Muscarinic

The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....

Articles linked to this work by shared authors, journal, and citation graph.

Dose-dependent white matter changes associated with repetitive head impacts in former American football players.

Brain communications·2026

Agonist-specific conformational dynamics at the β2-adrenoceptor dictate allosteric modulation of Gαs signalling and bronchodilation.

British journal of pharmacology·2026

A regulatory TRIF/IL-1R1 axis controls T-dependent IgA production in the intestines.

bioRxiv : the preprint server for biology·2026

Qualitative beta-2-adrenoceptor signaling in the regulation of human airway epithelia mucin and cytokine production.

Respiratory research·2026

Shape analysis of the amygdala, hippocampus and thalamus in former American football players.

Brain communications·2025

The differential effects of cAMP mobilizing agents on TGF-β-induced extracellular matrix in human lung-derived fibroblasts: insights into therapeutic targets for lung fibrosis.

Respiratory research·2025

See all related articles